{"id":"W4317862782","doi":"10.1200/jco.2023.41.4_suppl.489","title":"NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"National Institutes of Health","keywords":"Medicine; Sorafenib; Hepatocellular carcinoma; Clinical endpoint; Internal medicine; Adverse effect; Randomized controlled trial; Quality of life (healthcare); Oncology; Proportional hazards model; Interim analysis; Progression-free survival; Nuclear medicine; Overall survival; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002996736,0.00196689,0.002786828,0.0006312277,0.0003716702,0.001077385,0.001109805,0.001332888,0.009218176],"category_scores_gemma":[0.001880955,0.0008784667,0.001607626,0.0005808676,0.001153034,0.0008876341,0.0004589221,0.003098721,0.001860639],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001117876,"about_ca_system_score_gemma":0.002056324,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001486927,"about_ca_topic_score_gemma":0.003625141,"domain_scores_codex":[0.9990487,0.0006130013,0.00004219335,0.0001052725,0.00005328573,0.0001376476],"domain_scores_gemma":[0.9990544,0.0002244134,0.0001904165,0.00006647777,0.00004272231,0.0004215713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9772424,0.008385696,0.0004172779,0.0003362554,0.0003461659,0.00002655304,0.00003379359,0.0004124991,0.002172714,0.00008187918,0.0006661328,0.009878681],"study_design_scores_gemma":[0.9353127,0.06267767,0.0007825949,0.00001503313,0.000160913,0.00001953301,0.00001181263,0.000322015,0.0002419789,0.0000734472,0.0003747803,0.000007583148],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836419,0.002144717,0.0007548992,0.0008985594,0.0006558941,0.007344071,0.00181122,0.0001902598,0.002558448],"genre_scores_gemma":[0.9788957,0.002111076,0.002193555,0.001210233,0.0004963136,0.007937751,0.001851859,0.00005244184,0.005251131],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009218176,"threshold_uncertainty_score":0.03083789,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1516899067531719,"score_gpt":0.424279012922167,"score_spread":0.2725891061689951,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}